|
|
Exchange: |
New York Stock Exchange |
Security
Type: |
Common |
Shares
Out: |
1,430,000,000 |
Market
Cap: |
105.38(B) |
Last
Volume: |
3,790,549 |
Avg
Vol: |
8,454,629 |
52
Week Range: |
$48.64 - $74.1 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Health Services |
Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
|
S&P 500 |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 297 |
Guru Rank Value : 4.1 |
Guru Occurances : 2 |
|
|
|
|
|
|
|
Company Profile Boston Scientific develops, manufactures and markets medical devices. Co.'s Medical Surgical segment consist of: Endoscopy, which develops and manufactures devices to diagnose and treat a range of gastrointestinal and pulmonary conditions; and Urology and Pelvic Health, which develops and manufactures devices to treat various urological and pelvic conditions. Co.'s Rhythm and Neuro segment includes: Cardiac Rhythm Management, which develops and manufactures implantable devices to treat cardiac abnormalities; and Electrophysiology, which develops and manufactures medical technologies used in the diagnosis and treatment of rate and rhythm disorders of the heart.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
125,097 |
292,774 |
846,826 |
1,890,829 |
Total Sell Value |
$8,578,386 |
$18,202,620 |
$47,460,549 |
$93,238,165 |
Total People Sold |
7 |
8 |
10 |
13 |
Total Sell Transactions |
13 |
22 |
39 |
73 |
End Date |
2024-02-11 |
2023-11-10 |
2023-05-12 |
2022-05-12 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Bartlett Katharine T |
Director |
|
2011-11-28 |
4 |
B |
$5.42 |
$43,360 |
D/D |
8,000 |
29,708 |
2.39 |
- |
|
Mario Ernest |
Director |
|
2011-11-21 |
4 |
B |
$5.30 |
$132,500 |
D/D |
25,000 |
306,004 |
2.39 |
- |
|
Connors Nelda J |
Director |
|
2011-11-14 |
4 |
S |
$5.84 |
$14,600 |
D/D |
(2,500) |
0 |
|
- |
|
Pierce David A |
SVP and President, Endoscopy |
|
2011-11-04 |
4 |
S |
$5.77 |
$91,548 |
D/D |
(15,869) |
4 |
|
- |
|
Pucel Kenneth |
EVP, Global Ops & Technology |
|
2011-10-31 |
4 |
D |
$5.89 |
$12,522 |
D/D |
(2,126) |
90,724 |
|
- |
|
Pucel Kenneth |
EVP, Global Ops & Technology |
|
2011-10-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,500 |
92,850 |
|
- |
|
Kucheman William |
Chief Executive Officer |
|
2011-10-31 |
4 |
D |
$5.89 |
$12,157 |
D/D |
(2,064) |
79,030 |
|
- |
|
Kucheman William |
Chief Executive Officer |
|
2011-10-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,500 |
81,094 |
|
- |
|
Onuscheck John Michael |
SVP & President, EMEA |
|
2011-10-31 |
4 |
D |
$5.81 |
$4,880 |
D/D |
(840) |
44,730 |
|
- |
|
Nanavaty Maulik |
SVP & President, Neuromodula |
|
2011-10-31 |
4 |
D |
$5.81 |
$9,703 |
D/D |
(1,670) |
48,246 |
|
- |
|
Onuscheck John Michael |
SVP & President, EMEA |
|
2011-10-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,290 |
45,570 |
|
- |
|
Nanavaty Maulik |
SVP & President, Neuromodula |
|
2011-10-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,580 |
49,916 |
|
- |
|
Mario Ernest |
Director |
|
2011-10-25 |
4 |
B |
$5.50 |
$137,500 |
D/D |
25,000 |
256,004 |
2.39 |
- |
|
Spriggs Otha T. Iii |
SVP, Human Resources |
|
2011-09-07 |
4 |
D |
$6.49 |
$14,836 |
D/D |
(2,286) |
4,912 |
|
- |
|
Spriggs Otha T. Iii |
SVP, Human Resources |
|
2011-09-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,198 |
7,198 |
|
- |
|
Neumann Lawrence R |
SVP and President, Emerging Ma |
|
2011-09-06 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
65,540 |
|
- |
|
Pierce David A |
SVP and President, EndoscopyOf |
|
2011-09-06 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
15,873 |
|
- |
|
Nanavaty Maulik |
SVP & President, NeuromodulaOf |
|
2011-09-06 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
45,336 |
|
- |
|
Pedersen John B. |
Pres, Uro & Womens Health |
|
2011-08-11 |
4 |
S |
$5.97 |
$12,304 |
D/D |
(2,061) |
0 |
|
- |
|
Mario Ernest |
Director |
|
2011-08-03 |
4 |
B |
$6.70 |
$670 |
I/I |
100 |
22,600 |
2.02 |
- |
|
Mario Ernest |
Director |
|
2011-08-02 |
4 |
B |
$6.82 |
$682,230 |
D/D |
100,000 |
231,004 |
2.39 |
- |
|
Onuscheck John Michael |
SVP & Pres-Neuromodulation |
|
2011-08-01 |
4 |
D |
$6.92 |
$7,916 |
D/D |
(1,144) |
43,280 |
|
- |
|
Onuscheck John Michael |
SVP & Pres-Neuromodulation |
|
2011-08-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,118 |
44,424 |
|
- |
|
Fitzgerald Joseph Michael |
SVP & President, CRM |
|
2011-07-29 |
4 |
D |
$7.16 |
$15,616 |
D/D |
(2,181) |
57,551 |
|
- |
|
Fitzgerald Joseph Michael |
SVP & President, CRM |
|
2011-07-29 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,667 |
59,732 |
|
- |
|
1823 Records found
|
|
Page 24 of 73 |
|
|